Sueoka N - Search Results

1

Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.

Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM. Sueoka N, et al. Oncogene. 2000 Sep 7;19(38):4432-6. doi: 10.1038/sj.onc.1203813. Oncogene. 2000. PMID: 10980619

2

Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.

Sueoka N, Lee HY, Walsh GL, Hong WK, Kurie JM. Sueoka N, et al. Cancer Res. 1999 Aug 1;59(15):3838-44. Cancer Res. 1999. PMID: 10447003

3

Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment.

Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Sueoka N, et al. Am J Respir Cell Mol Biol. 2000 Sep;23(3):297-303. doi: 10.1165/ajrcmb.23.3.4013. Am J Respir Cell Mol Biol. 2000. PMID: 10970819

4

All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity.

Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret FX, Kurie JM. Lee HY, et al. Among authors: sueoka n. Mol Cell Biol. 1999 Mar;19(3):1973-80. doi: 10.1128/MCB.19.3.1973. Mol Cell Biol. 1999. PMID: 10022884 Free PMC article.

5

Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.

Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. Suganuma M, et al. Among authors: sueoka e, sueoka n. Cancer Res. 1999 Jan 1;59(1):44-7. Cancer Res. 1999. PMID: 9892181

6

Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.

Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H. Suganuma M, et al. Among authors: sueoka n. Cancer Res. 2001 Sep 1;61(17):6356-9. Cancer Res. 2001. PMID: 11522625

7

Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.

Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Sueoka E, et al. Among authors: sueoka n. Cancer Res. 1999 Apr 1;59(7):1404-7. Cancer Res. 1999. PMID: 10197602

8

The role of interleukin-6 in inhibition of lung metastasis in subcutaneous tumor-bearing mice.

Inoue K, Okabe S, Sueoka E, Sueoka N, Tabei T, Suganuma M. Inoue K, et al. Among authors: sueoka e, sueoka n. Oncol Rep. 2000 Jan-Feb;7(1):69-73. doi: 10.3892/or.7.1.69. Oncol Rep. 2000. PMID: 10601594

9

Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression.

Sueoka N, Sueoka E, Okabe S, Fujiki H. Sueoka N, et al. Among authors: sueoka e. Carcinogenesis. 1996 Nov;17(11):2337-41. doi: 10.1093/carcin/17.11.2337. Carcinogenesis. 1996. PMID: 8968046

10

Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array.

Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H. Okabe S, et al. Among authors: sueoka n. Biol Pharm Bull. 2001 Aug;24(8):883-6. doi: 10.1248/bpb.24.883. Biol Pharm Bull. 2001. PMID: 11510478 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters